Erik van den Berg: CEO of Memo Therapeutics
Update: 2025-10-27
Description
Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
